EcoDrugPlus

Ribosomal Protein L30

Ensembl ID : ENSPNAG00000011570
Gene Symbol: RPL30
3 Cross references
413 Possible Orthologues:

Ribosomal Protein L31

Ensembl ID : ENSPNAG00000019513
Gene Symbol: RPL31
3 Cross references
651 Possible Orthologues:

Ribosomal Protein L32

Ensembl ID : ENSPNAG00000024938
Gene Symbol: RPL32
4 Cross references
236 Possible Orthologues:

Ribosomal Protein L34

Ensembl ID : ENSPNAG00000017412
Gene Symbol: RPL34
3 Cross references
362 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSPNAG00000019152
Gene Symbol: RPL35
3 Cross references
265 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSPNAG00000020201
Gene Symbol: RPL35A
3 Cross references
452 Possible Orthologues:

Ribosomal Protein L36

Ensembl ID : ENSPNAG00000022340
Gene Symbol: RPL36
3 Cross references
395 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSPNAG00000018334
Gene Symbol: RPL37
1 Cross references
432 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSPNAG00000004669
Gene Symbol: RPL38
3 Cross references
201 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSPNAG00000021555
Gene Symbol: RPL39
3 Cross references
543 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSPNAG00000014698
Gene Symbol: RPL4
3 Cross references
344 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSPNAG00000004187
Gene Symbol: RPL5
3 Cross references
404 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).